Skip to main content

Zachary Conrad Hartman

Associate Professor in Surgery
Surgery, Surgical Sciences
Box 2606 Med Ctr, Durham, NC 27710
Research Drive, MSRBI Rm 414, Durham, NC 27710

In the News


Published May 9, 2023
Coffee Talk: Immunology and Breast Cancer
Published January 31, 2023
Duke Researchers use mRNA Vaccine Technology to Work on Cancer Vaccine
Published June 27, 2022
Clinical trial begins for Duke breast cancer vaccine.
Published April 18, 2022
Cancer vaccine using same mRNA technology as in Covid jabs could be a 'game-changer', experts say.
Published April 16, 2022
Promising cancer vaccine in the works utilizing similar mRNA technology that combats COVID: Duke researchers
Published April 12, 2022
How close are we to a cancer vaccine? Duke University scientists are closing in.
Published March 29, 2022
UNC superfan, breast cancer survivor sets aside rivalry with Duke to raise $1.5M for research
Published March 18, 2022
New Insight in How Breast Cancer Drug Works Could Lead to Improvements
Published October 15, 2021
Komen Initiative Awards DCI & UNC Lineberger Teams $1.5M for MBC Research
Published September 8, 2021
eplicate Bioscience looks to replicate RNA's pandemic response success with $40M to go after cancers, immune disorders.
Published September 19, 2020
Vaccine Holds Promise to Improve Outcomes for MBC Patients.
Published August 4, 2020
riming HER2 breast cancer with a vaccine to improve PD-1 inhibition
Published July 31, 2020
New Duke vaccine 'works beautifully' against breast cancer.
Published July 30, 2020
Investigational breast cancer vaccine plus immune therapy work well in tandem.
Published November 14, 2019
Why a Leading Breast Cancer Treatment Works Is Still a Mystery. The Answer May Lead to New Therapies